| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| CAR_RIC - Bandi Fondazione Cariplo |
Dissecting the role of anti-GluA3 antibodies in Frontotemporal Dementia: from bench to bedside
|
|
Ongoing | 2022 |
| Progetti PNRR - per il potenziamento di strutture di ricerca e creazioni di campioni nazionali di R&S |
National Center for Gene Therapy and Drugs based on RNA Technology
|
|
Ongoing | 2022 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Metal-containing Radical Enzymes (MetRaZymes)
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
New interventional approaches on multiple inflammatory pathways involved in regeneration after trauma and aging- associated diseases
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Role of TDP-43 self-assembly in health and disEase: molecular characteristics, cellular Aspects and animal Models
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Escaping the ESKAPEs: integrated pipelines for new antibacterial drugs
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
Understanding, predicting, and treating depression in pregnancy to improve mothers and offspring mental health outcomes (HappyMums)
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Optimizing Management of Comorbid NASH through a Multidisciplinary Integration and Artificial Intelligence Alliance (OPTIMA-NASH)
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Pharmacological block of the prokineticin system and of microglia activation to treat pain and mood disorders in Fabry-Anderson disease
|
|
Closed | 2022 |
| Horizon Europe - European Partnership |
Partnership for the Assessment of Risks from Chemicals (PARC)
|
|
Ongoing | 2022 |
